Health Care Equipment & Services

Discover how Stryker’s acquisition of Amplitude Vascular Systems and RSU insider transactions reinforce corporate governance, expand peripheral vascular offerings, and boost investor confidence.

ResMed’s stable share price, strong 11 % revenue growth and 27 % operating margin show a resilient medical‑device leader poised to capitalize on AI‑driven RPM and value‑based care, making it a standout for investors and payers alike.

Quest Diagnostics’ $500 M 5% senior note issuance gives it the capital to boost high‑margin molecular tests, automate labs, and expand patient access while keeping debt‑service risk low.

Siemens Healthineers shares dip as revised earnings guide hits amid German market slump, but AI platform Cerebra signals future growth and resilience.

Fresenius SE & Co. KGaA edges higher in a cautious DAX session, its modest share‑price gain standing out amid a muted market and no new corporate announcements.

UnitedHealth Group shows steady earnings, a solid 2.1% dividend and tech‑driven growth, keeping investors confident in its value‑oriented healthcare strategy.

Fresenius Medical Care’s share jump shows investors see upside amid a cautious analyst downgrade, driven by solid fundamentals, home‑dialysis potential and integrated care growth.

Insulet’s Q1 2026 results show a 12.4% revenue lift, 46% net income jump, and $300 M share buyback, driven by Omnipod growth and cost control, promising strong shareholder value and patient‑care innovation.

CVS Health’s May 2026 earnings outlook shows stronger revenue, 15% debt reduction, and higher dividends, boosting its market value and Connecticut’s $200 M tax impact.

BDX Q2 2026 results: net loss amid higher integration costs but positive adjusted earnings, 3.6 % revenue growth, new CFO, and a bullish EPS outlook amid shifting reimbursement models.